decide Clinical Software GmbH

Managing blood glucose levels in hospitalized patients is one of the most common and delicate clinical challenges in modern medicine. In-hospital hyperglycemia — even in non-diabetic patients — is associated with significant complications, including increased mortality. Yet insulin therapy management in hospital wards is often handled through paper protocols, manual calculations, and clinical decisions made under time pressure. Decide Clinical Software addresses this problem with GlucoTab, an intelligent blood glucose management software system for hospital use. GlucoTab is designed to support healthcare professionals in managing insulin therapy for inpatients. The system guides the clinician through a structured dosing process, adapting recommendations to individual patient data and integrating into the ward's workflow. The goal is to reduce variability in therapeutic decisions, minimize the risk of iatrogenic hypoglycemia, and improve overall glycemic control during hospitalization. Decide Clinical Software's customers are hospitals, clinical departments — particularly internal medicine, surgery, and intensive care — and the healthcare professionals who manage patients with glycemic control issues in these settings. This is a B2B market in which the end client is the hospital, which adopts the software as a clinical decision support tool. The broader market context is clinical decision support, a growing segment within healthtech driven by the digitization of hospital processes and increasing attention to patient safety. GlucoTab occupies a vertical, specialized position within this space — focused on a specific but pervasive clinical problem present in any hospital setting.